Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Apellis Pharmaceuticals (APLS) Shares Issued (2020 - 2025)

Historic Shares Issued for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to $797000.0.

  • Apellis Pharmaceuticals' Shares Issued fell 6881.85% to $797000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 8538.77%. This contributed to the annual value of $14.3 million for FY2024, which is 7991.41% down from last year.
  • Per Apellis Pharmaceuticals' latest filing, its Shares Issued stood at $797000.0 for Q3 2025, which was down 6881.85% from $4.4 million recorded in Q2 2025.
  • Apellis Pharmaceuticals' Shares Issued's 5-year high stood at $380.1 million during Q1 2022, with a 5-year trough of $281000.0 in Q1 2025.
  • For the 5-year period, Apellis Pharmaceuticals' Shares Issued averaged around $53.2 million, with its median value being $5.1 million (2023).
  • Its Shares Issued has fluctuated over the past 5 years, first plummeted by 9932.18% in 2021, then soared by 1458778.98% in 2022.
  • Quarter analysis of 5 years shows Apellis Pharmaceuticals' Shares Issued stood at $368.2 million in 2021, then rose by 3.23% to $380.1 million in 2022, then crashed by 93.3% to $25.5 million in 2023, then plummeted by 98.74% to $321000.0 in 2024, then soared by 148.29% to $797000.0 in 2025.
  • Its last three reported values are $797000.0 in Q3 2025, $4.4 million for Q2 2025, and $281000.0 during Q1 2025.